HIIT for kids: a fun way to fight heart disease?

NCT ID NCT06416488

Recruiting now Disease control Sponsor: Children's Hospital of Fudan University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether a special high-intensity interval training (HIIT) program can improve heart health in school-age children who are at high risk for cardiovascular disease. The program involves short bursts of intense exercise, done several times a week. Researchers will track whether the children's blood sugar, cholesterol, and blood pressure return to healthier levels.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: high-intensity interval training (HIIT) exercise program
What this could lead to: If it works, this could offer a simple, drug-free way to improve heart health in children at risk for cardiovascular disease.
What could go wrong: This is a behavioral intervention, so results depend on kids sticking with the program. The study is not yet complete, and benefits may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR SYNDROME, METABOLIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

abdominal obesity-metabolic syndrome cardiovascular disorder hypertensive disorder inherited lipid metabolism disorder metabolic disease metabolic syndrome X Pediatric Obesity prediabetes syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOVASCULAR SYNDROME, METABOLIC

Contacts and locations

Locations

Children's Hospital of Fudan University
RECRUITING

Shanghai, Shanghai Municipality, 021, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.